Dr. Achim Rosemann
Achim is a researcher and educator specialising in the ethics, regulation, and global governance of artificial intelligence (AI), as well as emerging medical and bio-technologies. He teaches on AI Ethics, Governance and Society at the University of Cambridge’s Leverhulme Centre for the Future of Intelligence (CFI). From May 2025 to April 2026 he also served as expert consultant for UNESCO’s AI Ethics office, where he coordinated the development of the Global CSO and Academic Network on AI Ethics and Policy.
Prior to his work at the University of Cambridge, Achim worked as Senior Research Fellow at the Centre for Computing and Social Responsibility of De Montfort University, and as a Research Fellow at the Universities of Warwick, Exeter and Sussex.
He has an interdisciplinary background in social anthropology, technology ethics, and science and technology studies. His research and teachings have explored conceptual and policy-related questions in the following areas:
The transformative impact and governance of emerging technologies, with a focus on developments in AI, heritable genome editing, regenerative medicine, and industrial biotechnology.
The role and implications of global inequalities and differences on the ways in which emerging technologies are framed, used, commercialised, and governed.
The opportunities and constraints faced by civil society organisations in shaping technology deployment and governance, with a particular focus on developments in AI and related digital technologies and applications.
Achim's research has been funded by the ESRC, UKRI, the Wellcome Trust, the Nuffield Council on Bioethics, as well as research grants from the Universities of Warwick and Sussex.
His research has resulted in 50+ publications: (i) 28 refereed journal articles, of which many in leading social science journals (e.g., Social Studies of Science; Hastings Centre Report; Social Science & Medicine; Science & Public Policy; Science as Culture; Journal of Responsible Innovation; etc.), as well as scientific journals (e.g., Artificial Intelligence Review; Trends in Biotechnology; Regenerative Medicine, Stem Cell Research, etc.), (ii) 8 book chapters, (iii) 2 special issues, (iv) an edited book volume, as well as (v) research and policy briefs for the European Commission, the Nuffield Council on Bioethics, UNESCO, and others.